PECAM1 and neoplasm: To better identify the lymphatic vessels, and thus the lymphatic remodeling within the tumor and surrounding periphery, alternative established markers such as LYVE−1 in conjunction with CD31 may be used to identify the vessels as was done within the lymph node vessel analysis.